Included Health and the company are launching a prospective consented nationwide randomized study, pending Institutional Review Board (IRB) approval, to assess AI in a real-world virtual care setting. The research is described as a next step in testing AI systems capable of clinical reasoning and dialogue, with the aim of evaluating their utility and impact across more patients, geographies and conditions under controlled comparisons.
The study will build on earlier work on AI for diagnostic and management reasoning, personalized health insights and navigating health information. Those earlier studies, published in Nature, assessed the AI system’s diagnostic reasoning capabilities and its assistive effect for physicians, and compared its conversational diagnostic capabilities with those of primary care physicians in simulated settings with patient actors.
The company also said it explored a physician-centered paradigm with asynchronous oversight of AI. Its initial move into real-world clinical testing was a single-center feasibility study with Beth Israel Deaconess Medical Center. That study was designed to demonstrate safety using outcome measures such as the number of interruptions by the safety supervisor in response to safety concerns.
The company said it has observed strong indications of safety in that initial study and expects to share results when complete.
Source: research.google.
Companies can share verified announcements through Newz9’s international press release submission page.
